News

News

Adcock Ingram barred from selling painkiller in Aspen trademark battle

19 May 2025


The Pretoria High Court ordered pharmaceutical company Adcock Ingram to cease selling and distributing its newly launched painkilling drug, Lenbucod.
“The court found that the name infringed upon rival Aspen Pharmaceuticals' existing trademark, Mybucod. Aspen contended that the name ‘Lenbucod’ was confusingly similar to their established product, ‘Mybucod’ thereby constituting trademark infringement.” – BusinessDay (19 May 2025)

[BACK TO NEWS]